Durando, Xavier
Inserm · Université Clermont Auvergne · Centre Jean Perrin · Imagerie Moléculaire et Stratégies Théranostiques
2 papers on CoChatORCID 0000-0001-6035-3172
Most cited papers
- Verified
Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)
Thivat, E., Casile, M., Moreau, J., Molnar, I., Dufort, S., Seddik, K., Le Duc, G., De Beaumont, O., Loeffler, M., Durando, X., et al. (2023) · BMC Cancer
Glioma Diagnosis and TreatmentRadiation Therapy and Dosimetry
Cited by 76
- Verified
Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations
Figarella-Branger, D., Mokhtari, K., Dehais, C., Jouvet, A., Uro-Coste, E., Colin, C., Carpentier, C., Forest, F., Maurage, C.-A., Vignaud, J.-M., et al. (2014) · Neuro-Oncology
Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 63
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free